Heidi Abrahamse Faculty of Health Sciences University of Johannesburg Johannesburg (South Africa)
Prof. Abrahamse is presently serving as a Director in the Laser Research Center. She has been awarded a degree of PhD in Molecular Biology/Biochemistry from Wits University. Her research interests include photobiology and photochemistry with specific reference to photodynamic cancer therapy, nanotechnology and targeted cancer therapy investigating the intricate mechanisms underlying cancer cell death induced by novel photochemotherapeutic compounds in conjunction with the use of nanoparticles. Her international standing as a researcher of distinction is supported by the fact that she has hosted 3 international conferences and has been invited to present her research at several international conferences. Her publication record is impressive with 154 peer-reviewed accredited journal publications, 19 chapters and 3 books, and a Scopus H-index of 27.
Amirhossein Ahmadi Faculty of Pharmacy Mazandaran University of Medical Sciences Sari (Iran)
The experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. Skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. He has focused on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many originals and reviews in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, Dr. Amirhossein Ahmadi is ranked in the top 1% of the reviewers in Cross-Field on Publons global reviewer database.
Ahmed M. Al-Abd Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University Ajman (United Arab Emirates)
Dr. Al-Abd has been promoted in the fields of research/academia from research assistant to associate research professor at the National Research Centre of Egypt. He worked for 6 years as an Assistant/Associate Professor at King Abdul-Aziz University and supervised the research activities within the Tissue Culture facility in the Faculty of Pharmacy, King Abdul-Aziz University. He is currently an Associate Professor of Pharmaceutical Sciences at the Gulf Medical University, United Arab Emirates. In addition to his title, he is a visiting scholar in Bouvé College of Health Sciences, Northeastern University, USA.
Danciu Corina University of Medicine and Pharmacy "Victor Babes" Timisoara (Romania)
Dr. DANCIU CORINA is a Researcher, Pharmacist and the Head of Department of Pharmacognosy in Victor Babes University of Medicine and Pharmacy Timisoara. She has been awarded a degree of PhD in 2013. She has contributed her valuable 60 publications in different scientific journals. She is also a member of the editorial board of 6 international journals and co-author of patents. Her research interests include: quantitative and qualitative characterization of vegetal extracts, in vitro and in vivo evaluation of pure natural compounds or total extracts for different types of cancer, anti-inflammatory, antioxidant and antibacterial effect.
Viswanath Das Palack University Olomouc (Czech Republic)
Viswanath Das, M.Sc. in Biosciences with specialization in Biotechnology 2008, Sri Sathya Sai University, Puttaparthi, India; Ph.D. in Cell and Molecular Biology 2012, Victoria University of Wellington, Wellington, New Zealand; Postdoc, Institute of Molecular and Translational Medicine, Olomouc, Czech Republic 2015; Visiting fellow, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy 2015; Staff Scientist, Institute of Molecular and Translational Medicine, Olomouc, Czech Republic 2017; Assistant Professor, Institute of Molecular and Translational Medicine, Palacký University Olomouc, Czech Republic 2017. His research interest is in the repurposing of anti-cancer drugs for proteinopathy neurological disorders and the use of three-dimensional cell cultures as pathophysiologically relevant models for drug discovery and development.
Ibrahim H. Eissa Al-Azhar University Cairo (Egypt)
Ibrahim Hassan Eissa received his B.Sc. in 2003, Master’s degree in Medicinal Chemistry in 2009 and a PhD degree in 2012, both from the Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Since 2017, he has been an Associate Professor of Medicinal Chemistry at the Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar University and was made a manager of QAU in 2018. His scientific activity is focused on design, molecular modelling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, Carbonic anhydrases, and thymidylate synthase.
Jingkun Fang Nanjing University of Science and Technology Nanjing (China)
Dr. Jingkun Fang received both his B.Sc. and Ph.D. degrees from Hunan University in 2005 and 2010 respectively. During his Ph.D. period, he studied at the Okayama University of Science for 2 years under a joint Ph.D. program. After working in Changsha Research Institute of Mining and Metallurgy for nearly 3 years (2010-2013), he got a position as an associate professor at the Department of Chemistry in Nanjing University of Science and Technology (2013-present). He visited the Australian National University as a visiting scholar for 3 months in 2017. His research interests mainly focus on Organic Synthesis, Medicinal Chemistry, and Organic Functional Molecule.
Justin Lu University of Macau Macao (China)
Dr. Lu received his PhD degree in Shanghai Institute of Meteria Medica, Chinese Academy of Sciences in 2009. Since 2012, he joined University of Macau as an Assistant Professor and promoted to be Associate Professor in 2018. Dr. Lu mainly focuses on screening of natural compounds with anti-cancer potential and exploration of the molecular mechanisms. He is also interested in studying the new targets and strategies for cancer therapy. To present, Dr. Lu has published more than 140 scientific papers in the professional journals.
T.S. Morais Department of Chemistry and Biochemistry, Faculty of Sciences University of Lisbon Lisbon (Portugal)
Dr. Tânia Morais has been awarded a degree of PhD in Inorganic Chemistry in 2013 from the University of Lisbon. She was honored by the Portuguese Chemical Society in 2014 with the prize “Portuguese Young Chemist Award”. Currently, she is a researcher at Centro de Química Estrutural(CQE) at Faculdade de Ciências da Universidade de Lisboa (FCUL). Her research focuses on the design, synthesis and characterization of Ru, Fe and Cu complexes with targeting molecules (e.g. peptides, carbohydrates, and biomolecules) in their structure for the selective inhibition of the cancer development and metastases. She has 23 papers published in international journals, 3 book chapters and 3 patents.
Raffaele Pezzani Department of Medicine University of Padova Padova (Italy)
Prof. Raffaele Pezzani is a biologist and a physician with a PhD in Neuroscience at the University
of Padova, Italy. He has over 50 scientific publications that have more than 640 citations. He has
been serving as an editorial board member and as an editor of reputed impacted journals. He is
the principal investigator of his research group in Padova, having a long lasting and valid
experience (more than 20 years) in biology and medicine.
Palmiro Poltronieri Institute of Sciences of Food Productions, CNR-ISPA Bari (Italy)
Dr. Palmiro Poltronieri is presently serving as a researcher at the Agrofood Department of the Italian National Research Council. He holds a Ph.D. in Molecular and Cellular Biology from Verona University. His research interests include abiotic and biotic stress response in model plants, in bioactives from plants with a beneficial effect on health, in food microbiology and in the application of biocontrol strains for plant health. He is the co-founder of Biotecgen, a Small Medium Enterprise and service company, involved in European projects, such as RIBOREG, NANOMYC, ABSTRESS, and TOMGEM. He is Associate Editor to BMC Research Notes and is editor-in-chief for Challenges, an MDPI journal. He has co-authored 76 publications in international journals, 35 book chapters, and 5 books.
Siamak Salami Shahid Beheshti University of Medical Sciences Tehran (Iran)
Dr. Siamak Salami is currently working as and Associate Professor at Cell Death & Differentiation Signaling Research Lab in the Department of Clinical Biochemistry, School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran. He has completed his PhD in Biochemistry (Clinical/Molecular) from Tarbiat Modares University, Tehran, Iran in 2003. His research interests include the field of tissues processing, microscopic imaging methods and protein extraction, purification and characterization. He has had articles published in many well-renowned journals such as Journal of Cellular Biochemistry and Gene etc.
Manuel Scimeca Department of Biomedicine and Prevention University of Rome Tor Vergata Rome (Italy)
Dr. Manuel Scimeca, Biologist - Bachelor degree in "Cellular and molecular Biology" (2008); Masrer
degree in "Medical Biotechnology" (2011), PhD in "Medical Biotechnology and Translational Medicine"
(2015). Professor at University of Rome “Tor Vergata, “San Raffaele” University and “Saint Camillus
International University of Health and Medical Sciences”. Coordinator of Anatomic Pathology laboratory,
(University of Rome “Tor Vergata”) and Histology laboratory research (OrchideaLab). Post-Doc position
at University of Rome “Tor Vergata” for the project “Management of oncological patients”. Participant
in the European group of breast pathology studies. Member of the “Società Italiana di Anatomia
Patologica” (SIAPEC). Dr. Manuel Scimeca currently employs all basic and advanced techniques of the
histological area such as optical and electron microscopy, immunohistochemistry, in situ hybridization,
design and construction of Tissue Micro arrays (TMA), laser microdissection and capture.
Onur TOKGÜN Pamukkale University
Dr. Onur received his Ph.D. in Medical Biology and Genetics from the Pamukkale Institute of Medical
Sciences in 2017. After completion of his degree he got the Assist. Prof. position in the Department
of Medical Genetics at the University of Pamukkale, Denizli/TURKEY. His interests are focused on
cancer genetics and biology. In particular his laboratory is currently working on understanding the
role of exosomes in tumorgenesis. Dr. Tokgun has published several research papers in scientific
Qiang Yan Zhejiang University Zhejiang (China)
Qiang Yan is a medical doctor, master supervisor, adjunct professor and FACS, Chairman of
Department of General Surgery at Zhejiang University Huzhou Hospital, Director of
Department of Hepatopancreatic and Biliary Surgery and Department of Surgery Teaching
and Research. He is a member of Committees of Biliary Surgeons, Department of Surgeons
and Hepatobiliary Minimal of Non-invasive Surgery, Chinese Medical Doctor Association and
many other academic associations. He is a Special Reviewer of Journals of Medicine,
Oncotarget; Special Member of Editorial Committees of Chinese Journal of General Surgery,
Liver Cancer and Chinese Journal of Clinicians, a participant of High Level Talents of
Zhejiang Medicine and Zhejiang Province 151 Talents.
Lin Yang Affiliated Hospital of North Sichuan Medical College Sichuan (China)
Professor Lin Yang has received his B.S. in Clinical Medicine from Westchina Medical
University in 1990, M.S. in Surgery from Tianjin Medical University in 2001，and M.D. in
Imaging Medicine and Nuclear Medicine from Sichuan University in 2007, respectively. He
was employed as a professor of Imaging Medicine and Nuclear Medicine at Affiliated Hospital
of North Sichuan Medical College in 2012. Professor Lin Yang published about 80 journal
manuscripts, and seven academic books, respectively. He served as the Member of
Cardiovascular and Interventional Radiological Society of Europe (CIRSE), and Chinese
Society of Interventional Oncology; Deputy chairman of Sichuan Society of Interventional
Medicine, and Reviewers of J Vasc Interv Radiol, WJG, and Clinics, respectively.
Roberto S. da Silva University of Sao Paulo Sao Paulo (Brazil)
Dr. Roberto S. da Silva obtained his PhD (in 1993) from the The Universidade Estadual Paulista Brazil.
After that, he went for his Post-doctoral training to the York University-Canada. Currently, he is serving
as a Professor at the Pharmacy School, Monte Alegre, Ribeirao Preto – SP – Brazil. Dr. Roberto has
previously served as a reviewer in multiple prestigious Journals such as Inorganic Chemistry
Communications, Journal of Inorganic Biochemistry, Inorganic Chemistry etc. He was also an Editorial
Member of Journals such as Global Journal of Inorganic Chemistry, The Open Journal of Inorganic
Chemistry, The Eclética Química and still serves for the Journal ”Anti-cancer Agents in Medicinal
Chemistry”. Dr. Roberto has more than 100 publications under his belt with a total citation of more than
Simone Carradori Department of Pharmacy “G. d’Annunzio” University of Chieti-Pescara Chieti (Italy) Biography
Biography of Simone Carradori
Dr. Simone Carradori, after completing graduation in “Drug Chemistry and Technology”, obtained
his PhD in “Pharmaceutical Sciences” at the University of Rome "La Sapienza" (Italy). He
collaborates with several departments abroad. Currently, he is assistant professor at the Department
of Pharmacy of “G. d’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is
mainly focused on the synthesis and characterization of heterocyclic derivatives as well as
extraction of natural compounds with potential biological activity, and is documented from several
papers in international peer-reviewed journals, one European patent and participations in numerous